Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

SIM0660

2 posts
RRoche
Simcere Pharmaceutical Partners with Roche in Trispecific Antibody Licensing Deal Worth Up to $1.53 Billion — BigGo Finance
Read More

Simcere Pharmaceutical Partners with Roche in Trispecific Antibody Licensing Deal Worth Up to $1.53 Billion — BigGo Finance

  • 2026-09-02
Chinese innovative drugmaker Simcere Pharmaceutical (2096.HK) has entered into a global exclusive licensing collaboration with Swiss pharmaceutical giant…
RRoche
The Manila Times
Read More

Simcere Zaiming Enters Exclusive License Agreement with Roche for SIM0660 Global Development

  • 2026-09-01
NANJING, China, Sept. 1, 2026 /PRNewswire/ — Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced…
Switzerland
www.europesays.com